Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
132.55
-0.13 (-0.10%)
At close: Jun 26, 2026, 4:00 PM EDT
132.56
+0.01 (0.01%)
After-hours: Jun 26, 2026, 7:22 PM EDT
Apogee Therapeutics Employees
Apogee Therapeutics had 261 employees as of December 31, 2025. The number of employees increased by 65 or 33.16% compared to the previous year.
Employees
261
Change (1Y)
65
Growth (1Y)
33.16%
Revenue / Employee
n/a
Profits / Employee
-$1,052,165
Market Cap
9.93B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 261 | 65 | 33.16% |
| Dec 31, 2024 | 196 | 105 | 115.38% |
| Dec 31, 2023 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Madrigal Pharmaceuticals | 915 |
| Corcept Therapeutics | 730 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 673 |
| Halozyme Therapeutics | 423 |
| Krystal Biotech | 295 |
APGE News
- 7 hours ago - Healthcare stocks have become a haven for investors ditching tech - Market Watch
- 13 hours ago - Apogee Therapeutics Proxy statement: Proxy filing - Filings
- 1 day ago - Biotech ETF Index Surges 10% After Rebalance - ETF Trends
- 2 days ago - AbbVie's $11 Billion Immunology Bet - Forbes
- 2 days ago - Apogee Therapeutics downgraded to Hold from Buy at Stifel - TheFly
- 2 days ago - Apogee Therapeutics downgraded to Neutral from Outperform at Mizuho - TheFly
- 3 days ago - Apogee Therapeutics downgraded to Hold from Buy at TD Cowen - TheFly
- 3 days ago - Apogee Therapeutics downgraded to Neutral from Buy at Guggenheim - TheFly